Dolby Laboratories, Inc. (DLB) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 1070 transactions totaling $614.3M, demonstrating a bearish sentiment with -$614.3M in net insider flow. The most recent transaction on Feb 3, 2026 involved a transaction of 3,908 shares valued at $0.
No significant insider buying has been recorded for DLB in the recent period.
No significant insider selling has been recorded for DLB in the recent period.
Based on recent SEC filings, insider sentiment for DLB is bearish with an Insider Alignment Score of 0/100 and a net flow of -$614.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Dolby Laboratories, Inc. (DLB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading DLB stock, having executed 1070 transactions in the past 90 days. The most active insider is Kevin J. Yeaman (Executive), who has made 215 transactions totaling $218.3M.
Get notified when executives and directors at DLB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Tevanian Avadis | Executive | Award | 3,908 | $N/A | $0 | |
| Feb 3, 2026 | A. Prophet Tony | Executive | Award | 3,908 | $N/A | $0 | |
| Feb 3, 2026 | Sud Anjali | Executive | Award | 3,908 | $N/A | $0 | |
| Feb 3, 2026 | C. Gotcher Peter | Executive | Award | 3,908 | $N/A | $0 | |
| Feb 3, 2026 | Rollins Emily | Executive | Award | 3,908 | $N/A | $0 | |
| Feb 3, 2026 | Dolby David | Executive | Award | 3,908 | $N/A | $0 | |
| Feb 3, 2026 | Segars Simon | Executive | Award | 3,908 | $N/A | $0 | |
| Dec 17, 2025 | Andrew Sherman Mark | Executive | Sale | 2,491 | $67.26 | $167.5K | |
| Dec 17, 2025 | J. Yeaman Kevin | Executive | Sale | 80 | $67.54 | $5.4K | |
| Dec 17, 2025 | J. Yeaman Kevin | Executive | Sale | 6,671 | $67.24 | $448.6K | |
| Dec 16, 2025 | J. Park Robert | Executive | Payment | 2,285 | $66.62 | $152.2K | |
| Dec 16, 2025 | Andrew Sherman Mark | Executive | Payment | 2,530 | $66.62 | $168.5K | |
| Dec 16, 2025 | Andrew Sherman Mark | Executive | Sale | 6,738 | $66.58 | $448.6K | |
| Dec 16, 2025 | Andrew Sherman Mark | Executive | Sale | 2,371 | $67.17 | $159.3K | |
| Dec 16, 2025 | Revankar Shriram | Executive | Payment | 2,285 | $66.62 | $152.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 489 | $614.3M | 76.4% |
Exercise(M) | 231 | $157.3M | 19.6% |
Payment(F) | 110 | $32.2M | 4.0% |
Exercise (Options)(X) | 2 | $69.5K | 0.0% |
Purchase(P) | 1 | $200 | 0.0% |
Award(A) | 111 | $0 | 0.0% |
Gift(G) | 12 | $0 | 0.0% |
Conversion(C) | 114 | $0 | 0.0% |
Insider selling pressure at Dolby Laboratories, Inc. has increased, with 24 insiders executing 1070 transactions across all time. Total sales of $614.3M significantly outpace purchases of $200, resulting in a net outflow of $614.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.